May endocan be a new biomarker in the diagnosis of endometriosis?

Gamze Nur Cimilli Senocak, Gamze Nur Cimilli Şenocak, Omer Erkan Yapca, Ömer Erkan Yapça, Emsal Pınar Topdağı Yılmaz, Emsal Pınar Topdagi Yılmaz, Nurinnisa Öztürk, Nurinnisa Ozturk, Sevda Ozdes, Yakup Kumtepe
Journal of gynecology obstetrics and human reproduction · 2022 · vol. 51(7) , pp. 102423 · doi:10.1016/j.jogoh.2022.102423 · PMID:35691556 · W4281710688
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This paper investigates whether endocan can serve as a novel biomarker for diagnosing endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Proteoglycans Proteoglycans Proteoglycans Proteoglycans Proteoglycans Proteoglycans Proteoglycans Proteoglycans Proteoglycans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-27T00:34:43.004549+00:00
License: CC0 · commercial use OK